Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences Raises $20M in New Funding

NEW YORK (GenomeWeb News) – Menlo Park, Calif.-based Pacific Biosciences today said that it recently received $20 million in funding from new investor Blackstone Cleantech Venture Partners.
 
With the new funds, Pac Bio has raised $120 million in its latest financing round. It plans to use the resources to support its efforts to bring its Single-Molecule, Real-Time DNA sequencing platform to the market by the second half of 2010. The company said it has raised $193 million since it was founded in 2004.
 
Pac Bio also announced today that Elaine Mardis, co-director of the Washington University School of Medicine Genome Sequencing Center, has joined its scientific advisory board. Mardis, who has been at the Genome Sequencing Center since 1993, said in a statement that she is “convinced that Pacific Biosciences has the technology that will allow for dramatic advances in sequencing and truly enable ultra fast, accurate, and inexpensive DNA sequencing.”

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.